There have been no systematic reviews, let alone meta-analyses, of randomized controlled trials (RCTs) comparing tongxinluo capsule (TXL) and beta-blockers in treating angina pectoris. This study aimed to evaluate the efficacy of TXL and beta-blockers in treating angina pectoris by a meta-analysis of eligible RCTs.
Methods:
The RCTs comparing TXL with beta-blockers (including metoprolol) in treating angina pectoris were searched and retrieved from databases including PubMed, Chinese National Knowledge Infrastructure, and WanFang Data. Eligible RCTs were selected according to prespecified criteria. Meta-analysis was performed on the odds ratios (OR) of symptomatic and electrocardiographic (ECG) improvements after treatment. Subgroup analysis, sensitivity analysis, meta-regression, and publication biases analysis were conducted to evaluate the robustness of the results.
Results:
Seventy-three RCTs published between 2000 and 2014 with 7424 participants were eligible. Overall ORs comparing TXL with beta-blockers were 3.40 (95% confidence interval [CI], 2.97–3.89; p<0.0001) for symptomatic improvement and 2.63 (95% CI, 2.29–3.02; p<0.0001) for ECG improvement. Subgroup analysis and sensitivity analysis found no statistically significant dependence of overall ORs on specific study characteristics except efficacy criteria. Meta-regression found no significant except sample sizes for data on symptomatic improvement. Publication biases were statistically significant.
Conclusion:
TXL seems to be more effective than beta-blockers in treating angina pectoris, on the basis of the eligible RCTs. Further RCTs are warranted to reduce publication bias and verify efficacy.
Get full access to this article
View all access options for this article.
References
1.
Scottish Intercollegiate Guidelines Networks. Management of stable angina. National Institute for Health and Clinical Excellence clinical guideline 126. Issued July 2011; last modified December 2012. Online document at: http://www.nice.org.uk/guidance/cg126/resources/guidance-management-of-stable-angina-pdf, accessed August13, 2015.
2.
Scottish Intercollegiate Guidelines Networks. Management of stable angina. National Institute for Health and Clinical Excellence clinical guideline 96. Issued February 2007. Online document at: http://www.sign.ac.uk/pdf/sign96.pdf, accessed August13, 2015.
3.
JiaY, HuangF, ZhangS, LeungS. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol, 2012; 157:330–340.
4.
JiaY, ChenC, NgC, LeungS. Meta-analysis of randomized controlled trials on the efficacy of di'ao xinxuekang capsule and isosorbide dinitrate in treating angina pectoris. Evid Based Complement Alternat Med, 2012; 904147.
5.
JiaY, BaoF, HuangF, LeungS. Is tongxinluo more effective than isosorbide dinitrate in treating angina pectoris? A systematic review and meta-analysis of randomized controlled trials. J Altern Complement Med, 2011; 17:1109–1117.
6.
JiaY, ZhangS, BaoF, HuangF, et al.Indirect comparison of tongxinluo capsule and danshen dripping pill for angina pectoris: a systematic review. Chin J Evid Based Med, 2011; 11:919–931.
7.
WangJ. Yiling Group: opening up the market of Chinese medicine by innovation. J Chin Drugstore, 2010; 4:124–126.
8.
Chinese Pharmacopoeia Committee. Chinese Pharmacopoeia. 2010 edition. Beijing: Chin Med Sci Press, 2010.
9.
LiaoY, DengY, LiuX, DengJ, et al.Efficacy observe of tongxinluo capsule for treating chronic cardiac failure. Chin J Integr Med, 2003; 1:29–30.
10.
WuYL. Luobing doctrine in traditional Chinese medical science and cardia-cerebrovascular disease. Beijing: Chin Sci Tech Press, 2001.
11.
MoherD, LiberatiA, TetzlaffJ, AltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 2009; 89:873–880.
12.
HigginsJP, GreenS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Oxford: The Cochrane Collaboration, 2011.
13.
JadadAR, MooreRA, CarrollD, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials, 1996; 17:1–12.
14.
GuyattGH, OxmanAD, VistGE, et al.GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008; 336:924–926.
15.
GuyattGH, OxmanAD, KunzR, et al.What is “quality of evidence” and why is it important to clinicians?. BMJ, 2008; 336:995–998.
16.
GibbonsRJ, AbramsJ, ChatterjeeK, et al.ACC/AHA 2002 guideline update for the management of patients with chronic stable angina summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation, 2003; 107:149–158.
17.
LewisT. PROC LOGISTIC: the logistics behind interpreting categorical variable effects. Stat Data Analy, 2007:1–7.
18.
BreierovaL, ChoudhariM, ForresterJW. An introduction to sensitivity analysis. Massachusetts Instit Tech, 2001; 10:41–107.
19.
HigginsJP, ThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002; 21:1539–1558.
20.
ThompsonSG, HigginsJP. How should meta-regression analyses be undertaken and interpreted?. Stat Med, 2002; 21:1559–1573.
21.
SterneJA, EggerM. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol, 2001; 54:1046–1055.
22.
EggerM, Davey SmithG, SchneiderM, MinderC. Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis. BMJ, 1997; 316:629–634.
23.
BeggCB, MazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994; 50:1088–1101.
24.
DuvalS, TweedieR. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 2000; 56:455–463.
25.
R Development Core Team. R: a language and environment for statistical computing. Reference index version 2.12.0. Vienna, Austria: R Foundation for Statistical Computing, 2005.
26.
ViechtbauerW. Conducting meta-analyses in R with the metafor package. J Stat Software, 2010; 36:1–48.
27.
CaiHJ. Clinical investigation of tongxinluo capsule on coronary atherosclerotic heart disease angina pectoris accompany with hyperlipidemia. Hebei J Tradit Chin Med, 2006; 28:216–217.
28.
CaiZL, LiMF. Clinical investigation of tongxinluo capsule on treating patients with unstable angina pectoris. Chi Foreign Med Treat, 2010; 29:107.
29.
ChangSF, ZhaoM. Clinical investigation of tongxinluo capsule on treating patients with unstable angina pectoris. Mod J Integr Tradit Chin Med West Med, 2004; 13:189.
30.
ChenXH. Therapeutic investigation of tongxinluo capsule on treating exertional angina pectoris patients accompanied with hyperlipidemia. Acad J Guangdong Col Pharm, 2004; 20:81–82.
31.
ChenYJ, TianYF. Clinical investigation of tongxinluo capsule on treating patients with chronic stable angina pectoris. Proceedings of the Fourth International Convention of Collateral Disease Theory. Beijing: Chin Sci Tech Press, 2008: pp. 241–242.
32.
FanLJ. Clinical investigation of tongxinluo capsule on treating patients with coronary heart disease stable angina pectoris. J Guiyang Med Col, 2007; 32:521–522.
33.
FangML. Therapeutic investigation of the accessory treatment of tongxinluo capsule on treating patients with stable coronary heart disease. Chi J Clin Ration Drug Use, 2009; 2:36–37.
34.
GuoF, LinAM, WuSR, et al.Therapeutic investigation of the combination of tongxinluo capsule and western medicine on treating patients with coronary heart disease unstable angina pectoris. J Pract Tradit Chin Med, 2010; 26:706–707.
35.
GuoRB, ShangXZ, LiLM. Therapeutic investigation of tongxinluo capsule on treating patients with unstable angina pectoris. J Henan Univer Sci Tech (Med Sci), 2007; 25:192–193.
36.
GuoXH. Clinical investigation of tongxinluo capsule on treating patients with angina pectoris due to coronary heart disease. Chin Pract Med, 2009; 4:163–164.
37.
HeFX. Clinical investigation of tongxinluo capsule on treating elderly patients with unstable angina pectoris. J Emerg Tradit Chin Med, 2009; 18:914–916.
38.
HuMQ, PengZQ, HuangAY. Investigation of tongxinluo capsule on treating patients with coronary heart disease angina pectoris. Chin J Mode Drug App, 2008; 2:31–32.
39.
HuYM. Clinical investigation on the treatment of coronary heart disease angina pectoris and hyperlipidemia with integrated traditional Chinese medicines and western medicines. Shanxi J Tradit Chin Med, 2005; 21:24–25.
40.
LaiJT. Therapeutic investigation of tongxinluo capsule on treating elderly patients with coronary heart diseaseangina pectoris. Chin Med Pharm, 2012; 2:89–90.
41.
LiDM. Efficacy investigation of tongxinluo capsule in treating coronary heart disease unstable angina pectoris. Chin Manipulat Rehabilit Med, 2014; 2:84–86.
42.
LiH. Clinical investigation and treatment of stable exertional angina pectoris. Med Inform, 2010; 23:1109–1110.
43.
LiKH, LiJH. Curative effect investigation of tongxinluo capsule plus routine western medicine therapy for angina pectoris. J Liaoning Univer Tradit Chin Med, 2009; 11:101–102.
44.
LiYH. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Chin Pract Med, 2011; 6:179–180.
45.
LiYP. Therapeutic investigation of tongxinluo capsule on treating patients with coronary heart disease angina pectoris. Chin J School Doct, 2003; 17:486–488.
46.
LiaoHH. Efficacy investigation of tongxinluo capsule in treating unstable angina pectoris. Guid Chi Med, 2013; 16:318–320.
47.
LinHY, LiK, LiHY. Therapeutic investigation of tongxinluo capsule on treating patients with coronary heart disease angina pectoris. J Guangxi Tradit Chin Med Univer, 2004; 7:19–20.
48.
LinSY. Efficacy investigation of tongxinluo capsule in treating coronary heart disease angina pectoris. Med Forum Basic, 2014; 18:187–188.
49.
LiuHM, SunL, LiYS. Therapeutic investigation of the accessory treatment of tongxinluo capsule inn treating patients with coronary heart disease stable angina pectoris. Tianjin Pharm, 2006; 18:39–40.
50.
LiuJ. Therapeutic investigation of tongxinluo capsule inn treating patients with exertional angina pectoris. Clin J Anhui Tradit Chin Med, 2002; 14:143–144.
51.
LuoH. Efficacy investigation of tongxinluo capsule combination metoprolol in treating unstable angina pectoris. Guide Chin Med, 2013; 21:588–589.
52.
LuoXC, LiangXW, ChenWG. Therapeutic investigation of tongxinluo capsule in treating coronary heart disease angina pectoris patients accompanied with hyperlipidemia. Chin J Misdiag, 2007; 7:741.
53.
LuoXM. Clinical investigation of tongxinluo capsule in the treatment of patients with coronary heart disease angina pectoris. Chin Med Herald, 2010; 7:56–57.
54.
LuoY, YinYZ. Therapeutic effect and influence on C reactive protein of tongxinluo capsule in patients with unstable angina pectoris. Med Innov Chin, 2008; 35:18–19.
55.
MaYL, YuYH. Clinical investigation of tongxinluo capsule on treating unstable angina pectoris. Qinghai Med J, 2011; 41:71–72.
56.
QiW, QiH. Clinical investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Chin J Ethnomed Ethnopharm, 2010; 19:127–128.
57.
QuYX, ZhaoFY. Clinical investigation of tongxinluo capsule in treating patients with coronary heart disease unstable angina pectoris. Shaanxi J Tradit Chin Med, 2005; 26:621–623.
58.
ReNGL, SongZJ, HuYQ. Clinical investigation of the combination of tongxinluo capsule and western medicine in treating patients with coronary atherosclerotic heart disease. Health Must-Read J, 2012; 7:391.
59.
RenCX, XueXR. Investigation of tongxinluo capsule in treating patients with coronary heart disease accompanied with hyperlipidemia. Shanxi J Tradit Chin Med, 2011; 32:1306–1307.
60.
RuiHM, CaoCH. Therapeutic patients of tongxinluo capsule in treating patients with unstable angina pectoris. Henan Tradit Chin Med, 2010; 30:819–820.
61.
ShenGM, FanSM. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Chin J Prim Med Pharm, 2009; 16:1699.
62.
ShenJJ, WangM, HuangJY, et al.Therapeutic investigation of tongxinluo capsule in treating coronary heart disease angina pectoris. Zhejiang J Integr Tradit Chin Med West Med, 2006; 16:487–488.
63.
ShiCJ, CaiSL, ZhangJD. Efficacy investigation of tongxinluo capsule in treating coronary heart disease angina pectoris. Chin J New Clin Med, 2013; 6:544–546.
64.
ShiHY, LiuDJ. Clinical investigation of tongxinluo capsule in treating unstable angina pectoris patients with hyperlipidemia. Chin J Integr Med Cardio/Cerebrovascular Dis, 2007; 5:62–63.
65.
SunGL. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Clin J Chin Med, 2011; 20:40–41.
66.
SunL. Therapeutic investigation of tongxinluo capsule in treating elderly patients with coronary heart disease accompanied with hyperlipidemia. Proceedings of the First International Convention of Collateral Disease Theory. Chin Sci Tech Press. 2005:201–202.
67.
SunL, LiuXJ, ZhangP. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Chin Med Pharm, 2012; 14:47–48.
68.
TaoY, DaiXH, DongM, ShaoZB, et al.Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Clin J Tradit Chin Med, 2007; 19:370–371.
69.
WangB, YangF, OuYangJP. Therapeutic investigation of tongxinluo capsule in treating patients with coronary atherosclerotic heart disease. Chin J Mode Drug App, 2009; 3:102–103.
70.
WangFL, GuoYH. Effect investigation of tongxinluo capsule in the treatment of coronary heart disease angina pectoris. Chin J Clin Ration Drug Use, 2011; 4:8–9.
71.
WangG, LiJP. Influence of tongxinluo capsule on Serum IL-18 and hs-CRP in elderly patients with coronary heart disease angina pectoris. Guangdong Med J, 2012; 33:276–278.
72.
WangLY. Curative effect investigation on senile coronary heart disease treated with tongxiluo capsule. Heilongjiang Med J, 2007; 31:52–53.
73.
WangZL, LuJP, ZhangHJ. Clinical investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. J Med Research, 2006; 35:81–82.
74.
WeiMS, MaXM. Therapeutic investigation of tongxinluo capsule in treating patitnts with coronary heart disease angina pectoris. J Qiqihar Med Col, 2001; 22:860.
75.
WeiZH, YangCH, LiYZ. Therapeutic investigation of tongxinluo capsule in treating patients with stable angina pectoris. Chin Mode Doct, 2009; 47:229.
76.
WuSP. Clinical investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. J Med Theory Pract, 2004; 17:1047–1048.
77.
XianLL. Clinical investigation on the therapeutic effects of tongxinluo in treating senile coronary heart disease complicated with hyperlipidemia. Proceedings of the Second International Convention of Collateral Disease Theory. Beijing: Chin Sci Tech Press. 2006:305–306.
78.
XiuYJ. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease unstable angina pectoris. Med J Chin People Health, 2008; 20:969–1002.
79.
XuS. Clinical investigation of tongxinluo capsule in treating patients with coronary heart disease unstable angina pectoris. Chin Health Indust, 2011; 8:44.
80.
XuYM, ZhuY. Clinical investigation of tongxinluo capsule in treating elderly patients with coronary heart disease angina pectoris. Chin Med Herald, 2006; 27:113–114.
81.
YangL. Therapeutic investigation of tongxinluo capsule in treating patients with stable angina pectoris. Mode J Integr Trad Chin West Med, 2005; 14:2365.
82.
YaoFN. Therapeutic investigation of tongxinluo capsule in treating patients with unstable angina pectoris. Chin J Integr Medn Cardio-/Cerebrovascular Dis, 2003; 1:244.
83.
YaoMC, ZhouJH. The influence of tongxinluo capsule on hemodynamics in patients with unstable angina pectoris. Clin Med, 2012; 32:118–119.
84.
YeMF. The clinical investigation of tongxinluo capsule on refractory intractable angina by conventional therapy. Guid Chin Med, 2008; 22:55–56.
85.
YouHZ. Therapeutic investigation of tongxinluo capsule on coronary heart disease angina pectoris. Proceedings of the Fourth International Convention of Collateral Disease Theory. Beijing: Chin Sci Tech Press, 2008:239–240.
86.
YuYS, HuN. Therapeutic investigation of the combination of tongxinluo capsule and metoprolol in treating patients with unstable angina pectoris. Med Innov Chin, 2012; 9:17–18.
87.
ZhanYM, ZhuF, XuXP. Clinical investigation of tongxinluo capsule in treating patients with unstable angina pectoris. Mod J Integr Tradit Chin West Med, 2011; 20:1331–1332.
88.
ZhangJ, LiGW. The efficacy of tongxinluo capsule in the treatment of patients with unstable angina. Med J West Chin, 2009; 21:1352–1353.
89.
ZhangNL. Clinical investigation of the combination of tongxinluo capsule and western medicine in treating patients with coronary atherosclerotic heart disease angina pectoris. Strait Pharm J, 2012; 24:121–123.
90.
ZhangRZ. Therapeutic investigation of the accessory treatment of tongxinluo capsule in treating patients with unstable angina pectoris. Guangming J Chin Med, 2011; 26: 2233–2234.
91.
ZhangSR, ChenZG, LvFH, et al.Efficacy investigation of tongxinluo capsule on microcirculatory changes of nail bed and hemorrheology in patients with coronary artery disease angina pectoris. Chin J Integr Tradit West Med Intens Critical Care, 2006; 13:237–239.
92.
ZhangWL, ZhuWH. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Shanxi J Tradit Chin Med, 2005; 26:1142.
93.
ZhangXQ, PanZH, XuYL, WangYC. Clinical investigation of tongxinluo capsule in treating elderly patients with coronary heart disease angina pectoris. Geriat Health Care, 2000; 6:102–103.
94.
ZhangYQ, ZhangX. Clinical investigation of tongxinluo capsule in treating coronary heart disease angina pectoris patients with hyperlipidemia. Chin J Integr Med Cardio/Cerebrovasc Dis, 2005; 3:1008–1009.
95.
ZhaoJL, XuDY. Therapeutic investigation of tongxinluo capsule in treating patients with stable exertional angina pectoris. Zhejiang J Integr Tradit Chin West Med, 2008; 18:755.
96.
ZhaoLX. Therapeutic investigation of tongxinluo capsule in treating patients with angina pectoris. Chin Commun Doct, 2012; 14:197–198.
97.
ZhaoYW, NiuYG. Therapeutic investigation of tongxinluo capsule in treating patients with unstable angina pectoris. Chin Commun Doct, 2010; 12:141–142.
98.
ZhengHS. Controlled treatment analysis of tongxinluo capsule in treating patients with unstable angina pectoris. Chin J Misdiag, 2010; 10:2346–2347.
99.
ZhouQ, ShiWL, ZhangYY, et al.Clinical efficacy and safety investigation of tongxinluo capsule on coronary heart disease angina pectoris. Med Aesthet Cosmet, 2013; 1:29–30.
100.
ZhouY. Therapeutic investigation of tongxinluo capsule in treating patients with unstable angina pectoris. Mode J Integr Tradit Chin West Med, 2008; 17:18–19.
101.
ZhouYB, WangY. Clinical investigation of tongxinluo capsule in treating patients with coronary heart disease unstable angina pectoris. Proceedings of the Fifth International Convention of Collateral Disease Theory. Beijing: Chin Sci Tech Press. 2009:380–381.
102.
ZhuCH. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Zhejiang J Integr Tradit Chin West Med, 2011; 21:499–500.
103.
ZhuHY, ZhouLY. Therapeutic investigation of tongxinluo capsule in treating patients with coronary heart disease angina pectoris. Chin Med Mode Distance Edu Chin, 2012; 10:21–22.
104.
ZhuLC. Therapeutic investigation of tongxinluo capsule in treating coronary heart disease angina pectoris patients with hyperviscosemia. J Emerg Tradit Chin Med, 2006; 15:494–496.
105.
BerwangerO, RibeiroRA, FinkelsztejnA, et al.The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. J Clin Epidemiol, 2009; 62:387–392.
106.
LiuJ, KjaergardLL, GluudC. Misuse of randomization. A review of Chinese randomized trials of herbal medicines for chronic hepatitis B. Am J Chin Med, 2002; 30:173–176.
107.
WuT, LiY, BianZ, et al.Randomized trials published in some Chinese journals: how many are randomized?. Trials, 2009; 10:46.
108.
WangG, MaoB, XiongZY, et al.The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China. Clin Ther, 2007; 29:1456–1467.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
